El sndrome pie-mano es un efecto secundario frecuente que aparece 2-4 semanas despus de iniciar el tratamiento con sorafenib o sunitinib
Maintain balance with healthy routines A steady routine supports your mental and physical health while your body adjusts
Taking both together increases the risk of tachycardia, hypertension, and potentially dangerous drug interactions, especially in people with pre-existing heart conditions, arrhythmias, or uncontrolled high blood pressure
Some limited research has observed modest changes in cortisol patterns in patients treated with GLP-1 receptor agonists, but these effects appear to be secondary consequences of metabolic improvement rather than direct pharmacological actions on cortisol production
The most commonly reported effects include: Mild water retention during the first 2 to 4 weeks Occasional headaches, particularly at treatment initiation Redness or irritation at the injection site Tingling or numbness in the extremities Short term fatigue or flushing after injection Ipamorelins selectivity provides a meaningful safety advantage
